Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 30, 2026 52.98M
October 29, 2026 51.67M
October 28, 2026 47.64M
October 27, 2026 45.45M
October 26, 2026 46.91M
October 23, 2026 48.12M
October 22, 2026 55.65M
October 21, 2026 63.91M
October 20, 2026 67.55M
October 19, 2026 64.03M
October 16, 2026 58.49M
October 15, 2026 59.05M
October 14, 2026 59.66M
October 13, 2026 59.45M
October 12, 2026 55.39M
October 09, 2026 54.05M
October 08, 2026 54.07M
October 07, 2026 53.47M
October 06, 2026 54.50M
October 05, 2026 50.55M
October 02, 2026 54.68M
October 01, 2026 55.41M
September 30, 2026 57.84M
September 29, 2026 57.89M
September 28, 2026 59.73M
Date Value
September 25, 2026 59.02M
September 24, 2026 58.32M
September 23, 2026 65.07M
September 22, 2026 66.20M
September 21, 2026 68.04M
September 18, 2026 66.58M
September 17, 2026 69.96M
September 16, 2026 63.67M
September 15, 2026 65.12M
September 14, 2026 67.55M
September 11, 2026 66.34M
September 10, 2026 66.84M
September 09, 2026 67.16M
September 08, 2026 70.88M
September 04, 2026 68.77M
September 03, 2026 68.16M
September 02, 2026 67.67M
September 01, 2026 68.28M
August 31, 2026 72.41M
August 28, 2026 70.38M
August 27, 2026 70.78M
August 26, 2026 71.07M
August 25, 2026 70.59M
August 24, 2026 70.10M
August 21, 2026 73.62M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 556.15M
Amgen, Inc. 295.24B
Anika Therapeutics, Inc. 267.21M
BioCryst Pharmaceuticals, Inc. 2.646B
Imunon, Inc. 5.227M